ARISTOTLE study and sub-group analyses: Conspicuous points
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, vol.44, pp.14-25, 2016 (ESCI, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 44
- Publication Date: 2016
- Journal Name: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
- Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.14-25
- Dokuz Eylül University Affiliated: Yes
Abstract
Aristotle study is a phase III study which evaluates apixaban's safety and efficacy as comparing to warfarin in patients with nonvalvular AF (NVAF) having at least one stroke risk factor of apixaban. 18.201 patients were evaluated in this randomized, controlled, multicentered study. This review will overview of the Aristotle study and subgroup analysis.